NO986218L - FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100 - Google Patents

FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100

Info

Publication number
NO986218L
NO986218L NO986218A NO986218A NO986218L NO 986218 L NO986218 L NO 986218L NO 986218 A NO986218 A NO 986218A NO 986218 A NO986218 A NO 986218A NO 986218 L NO986218 L NO 986218L
Authority
NO
Norway
Prior art keywords
procedure
determining
brain protein
brain
protein
Prior art date
Application number
NO986218A
Other languages
English (en)
Other versions
NO986218D0 (no
Inventor
Jan Brundell
Lena Nyberg
Original Assignee
Sangtec Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangtec Medical Ab filed Critical Sangtec Medical Ab
Publication of NO986218L publication Critical patent/NO986218L/no
Publication of NO986218D0 publication Critical patent/NO986218D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Det er tilveiebrakt en assay-fremgangsmåte til å bestemme nærvær av hjerneprotein S-100 i en klinisk prøve, som anvender antistoffer rettet på epitoper i regionen fra ser l til asn 38, og fra thr82 til glu93 i aminosyresekvensen til B underenhet av humant SlOOB.
NO986218A 1996-07-05 1998-12-30 FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100 NO986218D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602677A SE9602677D0 (sv) 1996-07-05 1996-07-05 Methods for determining brain antigens
PCT/SE1997/001164 WO1998001471A1 (en) 1996-07-05 1997-06-27 Methods for determining the presence of brain protein s-100

Publications (2)

Publication Number Publication Date
NO986218L true NO986218L (no) 1998-12-30
NO986218D0 NO986218D0 (no) 1998-12-30

Family

ID=20403304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986218A NO986218D0 (no) 1996-07-05 1998-12-30 FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100

Country Status (13)

Country Link
EP (1) EP0931094B1 (no)
JP (1) JP2000515854A (no)
AT (1) ATE301671T1 (no)
AU (1) AU715797B2 (no)
BR (1) BR9710175A (no)
CA (1) CA2259413A1 (no)
DE (1) DE69733957T2 (no)
ES (1) ES2247633T3 (no)
IL (1) IL127278A0 (no)
NO (1) NO986218D0 (no)
NZ (1) NZ333408A (no)
SE (1) SE9602677D0 (no)
WO (1) WO1998001471A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555327B1 (en) * 1998-08-28 2003-04-29 Canag Diagnostics Ab Monoclonal antibodies against S100
DE69941627D1 (de) * 1998-11-05 2009-12-17 Univ Michigan Für krebs
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
WO2001023894A1 (de) * 1999-09-28 2001-04-05 Evotec Oai Ag Quantitative analyse und typisierung subzellulärer partikel
AU2001265714A1 (en) * 2000-06-14 2001-12-24 Universite Libre De Bruxelles Marker for neurodegenerative diseases and its use for drug screening targeted against said diseases
ES2394331B2 (es) * 2011-06-17 2013-07-15 Universidade De Santiago De Compostela Uso de un péptido antigénico aislado derivado de la proteína s100-beta no unido a una molécula mhc de clase ii en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i
ES2394972B2 (es) * 2011-06-17 2013-07-19 Universidade De Santiago De Compostela Péptido antigénico aislado derivado de la proteína s100-beta, procedimiento de identificación y su uso en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i.
CN102331502B (zh) * 2011-08-31 2013-12-04 内蒙古科慧生物科技有限责任公司 人s100蛋白(s-100)定量测定试剂盒
WO2014194329A1 (en) * 2013-05-31 2014-12-04 Banyan Biomarkers, Inc. NEURAL SPECIFIC S100β FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
CN111487409A (zh) * 2019-01-28 2020-08-04 艾维可生物科技有限公司 一种s100b蛋白的化学发光法检测试剂盒及其使用方法

Also Published As

Publication number Publication date
EP0931094B1 (en) 2005-08-10
SE9602677D0 (sv) 1996-07-05
AU3563397A (en) 1998-02-02
WO1998001471A1 (en) 1998-01-15
NZ333408A (en) 1999-05-28
IL127278A0 (en) 1999-09-22
CA2259413A1 (en) 1998-01-15
NO986218D0 (no) 1998-12-30
ATE301671T1 (de) 2005-08-15
JP2000515854A (ja) 2000-11-28
AU715797B2 (en) 2000-02-10
ES2247633T3 (es) 2006-03-01
EP0931094A1 (en) 1999-07-28
DE69733957D1 (de) 2005-09-15
DE69733957T2 (de) 2006-04-13
BR9710175A (pt) 2000-01-11

Similar Documents

Publication Publication Date Title
EP0751992A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
DK0536275T3 (da) Tumorvækstinhibitorer udledt fra væv, fremgangsmåde til deres fremstilling samt anvendelse heraf
CA2310888A1 (en) Monoclonal human natural antibodies
EP1102596A4 (en) PEPTIDANTAGONISTS OF ZONULIN AND METHODS FOR THE USE THEREOF
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
EA199800946A1 (ru) Концентрированный препарат антител
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
AU9363398A (en) Hepatitis c receptor protein cd81
ATE265533T1 (de) Saeugetierchemokine
NO986218D0 (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
KR910006478A (ko) 인체 트립타제 유사 단백질
EP0780472A3 (en) Stress proteins
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
WO2000017658A3 (en) Diagnosis of myocardial disease or stroke using factor ix activation peptide
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
ES2136534A1 (es) Uso de la cd-1 sacalina para la deteccion y seguimiento de la enfermedad celiaca.
ATE169332T1 (de) Monoklonaler antikörper gegen den extravillösen trophoblast
MX9707020A (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
IT1286182B1 (it) Impiego della relaxina o relassina, come nuovo agente farmacologico antistaminico per bloccare il rilascio di istamina nei tessuti in
IT1286183B1 (it) Uso della relaxina come agente farmacologico per la produzione di farmaci per la cura delle gestosi gravidiche

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application